Dilation Capital Management’s Sherwin-Williams SHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.3M Buy
47,590
+18,229
+62% +$6.28M 7.66% 3
2025
Q4
$9.51M Buy
29,361
+6,615
+29% +$2.21M 4.38% 12
2025
Q3
$7.88M Buy
22,746
+8,605
+61% +$3.03M 3.9% 12
2025
Q2
$4.86M Sell
14,141
-2,045
-13% -$708K 2.59% 17
2025
Q1
$5.65M Buy
16,186
+3,135
+24% +$1.1M 6.87% 7
2024
Q4
$4.44M Buy
+13,051
New +$4.87M 4.09% 12

Other funds holding SHW

Dilation Capital Management's SHW Position: Q1 2026 in Review

Dilation Capital Management increased its Sherwin-Williams (SHW) stake by 62% in Q1 2026, buying an estimated $6.28M and bringing the position to 47,590 shares worth $15.3M. The position accounts for 7.66% of the portfolio, ranked #3.

Dilation Capital Management first reported a position in SHW in Q4 2024 and has held it in 6 quarters since. 1,688 funds tracked by Wall St. Rank hold SHW as of Q1 2026.

  • Dilation Capital Management held 47,590 shares of Sherwin-Williams worth $15.3M as of Q1 2026.
  • Dilation Capital Management bought 18,229 Sherwin-Williams shares in Q1 2026, an estimated $6.28M.
  • Sherwin-Williams made up 7.66% of Dilation Capital Management's portfolio in Q1 2026, its #3 holding.
  • Dilation Capital Management first reported a position in Sherwin-Williams in Q4 2024 and has held it in 6 quarters since.
  • 1,688 funds tracked by Wall St. Rank held Sherwin-Williams as of Q1 2026.

Based on Dilation Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.